for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Senseonics Holdings Inc

SENS.A

Latest Trade

2.52USD

Change

0.01(+0.40%)

Volume

752,488

Today's Range

2.43

 - 

2.64

52 Week Range

0.35

 - 

3.90

As of on the NYSE MKT LLC ∙ Minimum 15 minute delay

Pricing

Previous Close
2.51
Open
2.64
Volume
752,488
3M AVG Volume
560.18
Today's High
2.64
Today's Low
2.43
52 Week High
3.90
52 Week Low
0.35
Shares Out (MIL)
284.24
Market Cap (MIL)
954.77
Forward P/E
-6.48
Dividend (Yield %)
--

Next Event

Senseonics Holdings Inc Annual Shareholders Meeting

Latest Developments

More

Senseonics Holdings Announces $50.0 Million Bought Deal Offering Of Common Stock

Senseonics Holdings Sees FY Revenue $12 Million To $15 Million

Senseonics Holdings Reports Q3 2020 Financial Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Senseonics Holdings Inc

Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company's Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user's mobile device, such as a smartphone, Apple Watch or tablet.

Industry

Medical Equipment & Supplies

Contact Info

20451 Seneca Meadows Pkwy

GERMANTOWN, MD

20876-7005

United States

+1.301.5157260

https://www.senseonics.com/

Executive Leadership

Stephen P. DeFalco

Independent Chairman of the Board

Timothy T. Goodnow

President, Chief Executive Officer, Director

Nick B.. Tressler

Chief Financial Officer, Treasurer, Secretary

Mukul Jain

Chief Operating Officer

Mirasol Panlilio

Vice President and General Manager - Global Commercial Operations

Key Stats

2.29 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.0K

2018

0.0K

2019

0.0K

2020(E)

0.0K
EPS (USD)

2017

-0.510

2018

-0.600

2019

-0.610

2020(E)

-0.425
Price To Earnings (TTM)
--
Price To Sales (TTM)
95.32
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-121.92
Return on Equity (TTM)
-103.40

Latest News

Latest News

BRIEF-Senseonics Holdings Reports Q1 Loss Per Share Of $0.21

* SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

BRIEF-Senseonics Says Due To Covid-19, Financing Activities And Cost-Reduction Initiatives Taken

* SENSEONICS - DUE TO COVID-19, FINANCING ACTIVITIES AND COST-REDUCTION INITIATIVES TAKEN, INCLUDING SIGNIFICANT HEADCOUNT REDUCTIONS

BRIEF-Senseonics Eversense Sensor Receives MRI Conditional Approval In Europe

* SENSEONICS EVERSENSE® SENSOR RECEIVES MRI CONDITIONAL APPROVAL IN EUROPE Source text for Eikon: Further company coverage:

BRIEF-Senseonics Holdings Says Unit Received $5.8 Mln In Loan Funding From Paycheck Protection Program

* SENSEONICS HOLDINGS INC - ON APRIL 22, UNIT RECEIVED $5.8 MILLION IN LOAN FUNDING FROM PAYCHECK PROTECTION PROGRAM Source: (https://bit.ly/2W1j7wF) Further company coverage:

BRIEF-Senseonics Enters Into New Credit Facilities With Funds Managed By Highbridge Capital Management, Llc

* SENSEONICS ENTERS INTO NEW CREDIT FACILITIES WITH CERTAIN FUNDS MANAGED BY HIGHBRIDGE CAPITAL MANAGEMENT, LLC

BRIEF-Senseonics Holdings Says Suspending Commercial Sales In United States Of Its 90-Day Eversense Continuous Glucose Monitoring System

* SENSEONICS HOLDINGS INC - SUSPENDING COMMERCIAL SALES IN UNITED STATES OF ITS 90-DAY EVERSENSE CONTINUOUS GLUCOSE MONITORING SYSTEM

BRIEF-Senseonics Holdings Says On Mar 22, Co & Solar Capital Ltd Terminated That Certain Loan And Security Agreement, Dated As Of July 16, 2019

* SENSEONICS HOLDINGS INC - ON MAR 22, CO & SOLAR CAPITAL LTD TERMINATED THAT CERTAIN LOAN AND SECURITY AGREEMENT, DATED AS OF JULY 16, 2019

BRIEF-Senseonics Exploring Strategic Options To Enhance Stakeholder Value

* SENSEONICS EXPLORING STRATEGIC OPTIONS TO ENHANCE STAKEHOLDER VALUE

BRIEF-Senseonics Announces The FDA Approval To Continue The Promise Sensor Clinical Study In An Extended Cohort To 365 Days To Gather Feasibility Data

* SENSEONICS ANNOUNCES THE FDA APPROVAL TO CONTINUE THE PROMISE SENSOR CLINICAL STUDY IN AN EXTENDED COHORT TO 365 DAYS TO GATHER FEASIBILITY DATA Source text for Eikon: Further company coverage:

BRIEF-Senseonics Reports At ATTD Glycemic Outcomes Across Adult Age Ranges With Real-World Eversense CGM Use

* SENSEONICS REPORTS AT ATTD GLYCEMIC OUTCOMES ACROSS ADULT AGE RANGES WITH REAL-WORLD EVERSENSE CGM USE Source text for Eikon: Further company coverage:

BRIEF-Senseonics Announces Partnership With Companion Medical

* SENSEONICS ANNOUNCES PARTNERSHIP WITH COMPANION MEDICAL Source text for Eikon: Further company coverage:

BRIEF-Senseonics Announces Extension Of Distribution Agreement With Roche Diabetes Care

* SENSEONICS ANNOUNCES EXTENSION OF DISTRIBUTION AGREEMENT WITH ROCHE DIABETES CARE

BRIEF-Senseonics - Co, Roche Are Continuing Discussions Regarding Potential Longer Term Extension Of Agreement

* SENSEONICS - ON DEC. 20, UNIT ENTERED INTO AMENDMENT WITH ROCHE TO THEIR MAY 23, 2016 DISTRIBUTION AGREEMENT TO EXTEND AGREEMENT TERM UNTIL JAN. 31, 2019

BRIEF-Senseonics Holdings Reports Q1 Loss Per Share $0.16

* SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Senseonics Holdings Files For Mixed Shelf Of Up To $200 Mln

* SENSEONICS HOLDINGS INC FILES FOR MIXED SHELF OF UP TO $200 MILLION - SEC FILING Source text: [https://bit.ly/2qJDrDR] Further company coverage:

BRIEF-Senseonics Holdings Files For Mixed Shelf Of Upto $200 Mln - SEC Filing

* SENSEONICS HOLDINGS INC FILES FOR MIXED SHELF OF UPTO $200 MILLION - SEC FILING Source text: [https://bit.ly/2GDV1lV] Further company coverage:

BRIEF-Senseonics Announces Favorable Outcome Of FDA Advisory Committee On The Eversense System

* SENSEONICS ANNOUNCES FAVORABLE OUTCOME OF FDA ADVISORY COMMITTEE ON THE EVERSENSE SYSTEM

BRIEF-Senseonics Holdings Inc. Reports Q4 Loss Per Share $0.12

* SENSEONICS HOLDINGS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Senseonics Announces Proposed Convertible Senior Subordinated Notes Offering

* SENSEONICS ANNOUNCES PROPOSED CONVERTIBLE SENIOR SUBORDINATED NOTES OFFERING

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up